Search Count: 12
![]() |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.13 Å Release Date: 2025-04-09 Classification: LIGASE Ligands: A1BGE |
![]() |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.98 Å Release Date: 2025-04-09 Classification: LIGASE Ligands: A1BGF |
![]() |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.65 Å Release Date: 2016-01-13 Classification: LIGASE/LIGASE INHIBITOR Ligands: 44J |
![]() |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.45 Å Release Date: 2015-09-02 Classification: LIGASE/LIGASE INHIBITOR Ligands: 44K |
![]() |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2015-09-02 Classification: LIGASE/LIGASE INHIBITOR Ligands: 44M, EDO |
![]() |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2015-09-02 Classification: LIGASE/LIGASE INHIBITOR Ligands: 590, EDO |
![]() |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2015-09-02 Classification: LIGASE/LIGASE INHIBITOR Ligands: 44L |
![]() |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.90 Å Release Date: 2015-09-02 Classification: LIGASE/LIGASE INHIBITOR Ligands: 594 |
![]() |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.60 Å Release Date: 2015-09-02 Classification: LIGASE/LIGASE INHIBITOR Ligands: 44N |
![]() |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2015-09-02 Classification: LIGASE/LIGASE INHIBITOR Ligands: 44O, EDO, DMS |
![]() |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:1.85 Å Release Date: 2015-09-02 Classification: LIGASE/LIGASE INHIBITOR Ligands: 44Q |
![]() |
Organism: Mycobacterium tuberculosis
Method: X-RAY DIFFRACTION Resolution:2.24 Å Release Date: 2015-09-02 Classification: LIGASE/LIGASE INHIBITOR Ligands: 44R, CL |












